BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22537210)

  • 1. Insulinemia and the risk of breast cancer and its relapse.
    Formica V; Tesauro M; Cardillo C; Roselli M
    Diabetes Obes Metab; 2012 Dec; 14(12):1073-80. PubMed ID: 22537210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and breast cancer in premenopausal women: Current evidence and future perspectives.
    Laudisio D; Muscogiuri G; Barrea L; Savastano S; Colao A
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():217-221. PubMed ID: 29730021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
    Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study.
    Bahl M; Ennis M; Tannock IF; Hux JE; Pritchard KI; Koo J; Goodwin PJ
    Breast Cancer Res Treat; 2005 Nov; 94(2):135-44. PubMed ID: 16261412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer.
    Gonullu G; Ersoy C; Ersoy A; Evrensel T; Basturk B; Kurt E; Oral B; Gokgoz S; Manavoglu O
    Cytokine; 2005 Aug; 31(4):264-9. PubMed ID: 15955709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome.
    Goodwin PJ; Ennis M; Bahl M; Fantus IG; Pritchard KI; Trudeau ME; Koo J; Hood N
    Breast Cancer Res Treat; 2009 Apr; 114(3):517-25. PubMed ID: 18437560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin and leptin levels in obese patients with and without breast cancer.
    Romero-Figueroa Mdel S; Garduño-García Jde J; Duarte-Mote J; Matute-González G; Gómez-Villanueva A; De la Cruz-Vargas J
    Clin Breast Cancer; 2013 Dec; 13(6):482-5. PubMed ID: 24084031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and cancer: what is the connection?
    Cannata D; Fierz Y; Vijayakumar A; LeRoith D
    Mt Sinai J Med; 2010; 77(2):197-213. PubMed ID: 20309918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obesity, insulin resistance and type 2 diabetes: risk factors for breast cancer].
    Scheen AJ; Beck E; De Flines J; Rorive M
    Rev Med Liege; 2011; 66(5-6):238-44. PubMed ID: 21826954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and hyperinsulinemia.
    Kaplan NM
    Prim Care; 1991 Sep; 18(3):483-94. PubMed ID: 1946784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and prognosis of breast cancer.
    Carmichael AR
    Obes Rev; 2006 Nov; 7(4):333-40. PubMed ID: 17038127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models.
    Das M; Ellies LG; Kumar D; Sauceda C; Oberg A; Gross E; Mandt T; Newton IG; Kaur M; Sears DD; Webster NJG
    Nat Commun; 2021 Jan; 12(1):565. PubMed ID: 33495474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and cancer: a 2013 synopsis.
    Buysschaert M; Sadikot S
    Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perimenopausal weight gain and progression of breast cancer precursors.
    Stoll BA
    Cancer Detect Prev; 1999; 23(1):31-6. PubMed ID: 9892988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
    Vigneri R; Frasca F; Sciacca L; Vigneri P; Frittitta L
    J Natl Cancer Inst; 2009 Jul; 101(14):1030-1; author reply 1031-2. PubMed ID: 19546433
    [No Abstract]   [Full Text] [Related]  

  • 18. The molecular contribution of TNF-α in the link between obesity and breast cancer.
    Weichhaus M; Broom I; Bermano G
    Oncol Rep; 2011 Feb; 25(2):477-83. PubMed ID: 21165572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperinsulinemia: a Cause of Obesity?
    Erion KA; Corkey BE
    Curr Obes Rep; 2017 Jun; 6(2):178-186. PubMed ID: 28466412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients.
    Can A; Alacacioglu A; Kucukzeybek Y; Erten C; Cokmert S; Demir L; Dirican A; Vedat Bayoglu I; Akyol M; Aslan F; Oktay Tarhan M
    J BUON; 2013; 18(4):845-50. PubMed ID: 24344007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.